2025 updates and future research As of March 28, 2025, heres whats new with weight loss medications including tirzepatide
Personalized Dosing Strategies and Genetic Insights for Your GLP-1 Response Individual tolerance and efficacy with semaglutide depend partly on genetic variation in peptide pathways controlling appetite, metabolism, and drug response
E.WeissmanM
HildebrandtMHoffmannCSherrill-MixSKeilbaughSHamadyMChenYet alHigh-fat diet determines the composition of the murine gut microbiome independently of obesity
Because this is a probiotic approach rather than a pharmaceutical one, the side effect profile is completely different from injectable GLP-1 medications
But when researchers dug into the science to see if this peptide BPC-157 lives up to the hype, the answer was a whole lot of not so fast. In research quality, thats the lowest level of evidence we have, the newsletter explained